Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02258204Phase 2Unknown
A Phase 2 trial of ketamine in ischemic stroke, sponsored by CHU Caen Normandie. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02258204.